PPAR-γ Agonists: Shifting Attention from the Belly to the Heart?
- 1 May 2004
- journal article
- editorial
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 24 (5) , 798-800
- https://doi.org/10.1161/01.atv.0000127311.38703.1f
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- Effect of Rosiglitazone on Common Carotid Intima-Media Thickness Progression in Coronary Artery Disease Patients Without Diabetes MellitusArteriosclerosis, Thrombosis, and Vascular Biology, 2004
- The Metabolic Syndrome is associated with advanced vascular damage in patients with coronary heart disease, stroke, peripheral arterial disease or abdominal aortic aneurysmEuropean Heart Journal, 2004
- Nitric Oxide Production and Regulation of Endothelial Nitric-oxide Synthase Phosphorylation by Prolonged Treatment with TroglitazoneJournal of Biological Chemistry, 2004
- Thiazolidinedione Use, Fluid Retention, and Congestive Heart FailureCirculation, 2003
- Troglitazone Antagonizes Tumor Necrosis Factor-α-induced Reprogramming of Adipocyte Gene Expression by Inhibiting the Transcriptional Regulatory Functions of NF-κBJournal of Biological Chemistry, 2003
- Vascular Inflammation Is Negatively Autoregulated by Interaction Between CCAAT/Enhancer-Binding Protein-δ and Peroxisome Proliferator-Activated Receptor-γCirculation Research, 2002
- Structure, Endothelial Function, Cell Growth, and Inflammation in Blood Vessels of Angiotensin II–Infused RatsCirculation, 2002
- Control of Vascular Cell Proliferation and Migration by PPAR-γDiabetes Care, 2001
- Modulation of Vascular Inflammation In Vitro and In Vivo by Peroxisome Proliferator–Activated Receptor-γ ActivatorsCirculation, 2000
- A novel therapy for colitis utilizing PPAR-γ ligands to inhibit the epithelial inflammatory responseJournal of Clinical Investigation, 1999